Silo Pharma earnings were -$4.5M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest SILO earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$832.8k, down 49.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SILO reported annual earnings of -$4.2M, with -3.8% growth.
On SILO's earnings call on Aug 12, 2026, Silo Pharma (NASDAQ: SILO) reported Q2 2026 earnings per share (EPS) of -$0.76, up 73.61% year over year. Total SILO earnings for the quarter were -$832.83 thousand. In the same quarter last year, Silo Pharma's earnings per share (EPS) was -$2.88.
As of the last Silo Pharma earnings report, Silo Pharma is currently losing money. Silo Pharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$4.47 million, a 8.65% decrease year over year.
What was SILO's earnings growth in the past year?
As of Silo Pharma's earnings date in Aug 12, 2026, Silo Pharma's earnings has grown year over year. SILO earnings in the past year totalled -$4.47 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.